Tarsus Pharmaceuticals, Inc.

Q3 2023 13F Holders

Symbol: TARS
CUSIP: 87650L103
Type: Equity
Class: COM
Num filings: 110
Total reported value, excl. options: $529 M

Compare 2023 Q3 to

Manager	Report Date	Value ($000)	Shares	Option Type